Na<sub>V</sub>channel variants in patients with painful and nonpainful peripheral neuropathy
Samir Wadhawan(Bristol-Myers Squibb (United States)), J. Robinson Singleton, David M. Simpson(Icahn School of Medicine at Mount Sinai), Stefan Kirov(Johns Hopkins University), Ryan Golhar(Johns Hopkins University), Pam Shlemon, Linda J. Bristow(Bristol-Myers Squibb (United States)), Ahmet Höke(Johns Hopkins University), Mary Catherine George, Simone Thomas, Alexandra Nmashie, Senda Ajroud‐Driss, Hristelina Ilieva(Thomas Jefferson University), Brett M. Morrison(Unknown), Jessica Robinson‐Papp(Icahn School of Medicine at Mount Sinai), Christopher H. Gibbons, Daniela M. Menichella(Northwestern University), Lyle W. Ostrow(Johns Hopkins University), Michael Polydefkis(Université Paris-Sud), Jeffrey C. Allen(NYU Langone Health), John Thompson(Hospital for Sick Children), Benjamin Joslin, Leslie K. Jacobsen(Johns Hopkins University), Sabeeha Mukit, Marlene Dodinval, Sandeep Sharma, A. Gordon Smith(Johns Hopkins University), David R. Cornblath(Johns Hopkins University), Pat G. Casey, Mohamed Khoshnoodi, John Michael Li(Johns Hopkins University), Saumya Pant(Johns Hopkins University), Roy Freeman(Beth Israel Deaconess Medical Center), Charlotte J. Sumner(Johns Hopkins University), Irfan Qureshi(Johns Hopkins University)
Cited by 38
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
|Movement Disorders|2022|775
Differences between human and mouse embryonic stem cells
|Developmental Biology|2004|715